Which COVID studies pose a biohazard? Lack of clarity hampers research

Posted on AllSides October 25th, 2022
From The Center
National Institutes of Health/Science Photo Library

When researchers at Boston University (BU) in Massachusetts inserted a gene from the Omicron variant of SARS-CoV-2 into a strain of the virus from the beginning of the pandemic, they were trying to understand why Omicron causes mild disease.

But the experiments, described in a 14 October preprint1, have ignited a red-hot controversy over what constitutes truly risky SARS-CoV-2 research — especially now that much of the world’s population has some immune protection from the virus and COVID-19 treatments are available.

Read full story


AllSides Media Bias Rating: Center
AllSides Media Bias Rating: Center
You disagree.
Thank you! Community votes alone don't determine our ratings, but are valuable feedback and can prompt us to do more research.
See full bias rating for Nature.com
Learn about media bias

More News about Coronavirus from the Left, Center and Right

From the Left

From the Center

From the Right